Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| DECHENG CAPITAL LLC | 02-12-2024 | 12-31-2023 | 24 | 357,920,713 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| Alpine Immune Sciences, Inc. | COM | 1 | $135,007,469 | 7,083,288 | 0.04 | 7,083,288 | +Inf | 12-31-2023 | |
| Zentalis Pharmaceuticals Inc. | COM | 2 | $31,808,682 | 2,099,583 | 0.01 | 2,099,583 | +Inf | 12-31-2023 | |
| Pacific Biosciences of California, Inc. | COM | 3 | $28,844,941 | 2,940,361 | 0.01 | 2,940,361 | +Inf | 12-31-2023 | |
| 10x Genomics, Inc. | CL A COM | 4 | $20,120,642 | 359,554 | 0.01 | 359,554 | +Inf | 12-31-2023 |
